Komori
Tohoku Chemical (7446) · TargetAdvanced

FY2017 consolidated revenue target of ¥31.5 billion and consolidated ordinary profit target of ¥345 million

First written in FY2016. 2 of 4 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2018-Q3.

4entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2017AdvancedFY2018-Q2 – FY2018-Q32016: 12017: 120172018: 22018
Same theme, other companies
Setting and Achieving Performance Targets Under the Medium-Term Management PlanA theme 890 companies write about · 87 as a headwind · 1169 as a tailwind

The whole theme swung hardest in 2021: 17 of 81 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 134 companies compared. The sentences above are computed from all 134.Comparing 200 of the theme's 1305 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2018-Q3AdvancedAnnual report

    「As a result, compared with the same quarter of the previous year, net sales increased by ¥920 million, or 4.0%, to ¥24,147 million; operating income increased by ¥152 million, or 106.5%, to ¥295 million; ordinary income increased by ¥153 million, or 87.2%, to ¥329 million; and net income attributable to owners of the parent increased by ¥222 million, or 212.9%, to ¥327 million, due to gains on sales of fixed assets and other factors.」

    Against the consolidated ordinary profit target of ¥291 million for the fiscal year ending September 2018, consolidated ordinary profit for the cumulative third quarter was ¥329 million, continuing to exceed the target. Revenue for the cumulative third quarter was ¥24.147 billion.
  2. FY2018-Q2AdvancedAnnual report

    「As a result, compared with the same quarter of the previous year, net sales increased by ¥1,176 million, or 7.5%, to ¥16,830 million; operating income increased by ¥173 million, or 130.1%, to ¥307 million; ordinary income increased by ¥175 million, or 116.9%, to ¥325 million; and net income attributable to owners of the parent increased by ¥211 million, or 180.7%, to ¥328 million, due to gains on sales of fixed assets and other factors.」

    Against the ordinary profit target of ¥291 million for the fiscal year ending September 2018, ordinary profit for the cumulative second quarter was ¥325 million, exceeding the target. Revenue for the cumulative second quarter was ¥16.83 billion.
  3. FY2017Target deadline reached; target not achievedAnnual report

    「As a result, compared with the previous year, net sales increased by ¥765 million, or 2.5%, to ¥30,862 million; operating income increased by ¥4 million, or 2.4%, to ¥202 million; ordinary income increased by ¥10 million, or 4.4%, to ¥242 million; and net income attributable to owners of the parent increased by ¥8 million, or 6.5%, to ¥133 million, due to gains on sales of investment securities and other factors, despite tax-effect adjustments related to consolidated subsidiaries.」

    For the fiscal year ended September 2017, revenue was ¥30.862 billion and ordinary profit was ¥242 million, falling short of the previous targets of ¥31.5 billion in revenue and ¥345 million in ordinary profit.
  4. FY2016First statedAnnual report

    「Target achievement period         Fiscal year ending September 2017  Consolidated revenue         ¥31.5 billion  Consolidated ordinary profit        ¥345 million」

    Under the medium-term management plan, the fiscal year ending September 2017 was set as the target achievement period, with consolidated revenue of ¥31.5 billion and consolidated ordinary profit of ¥345 million established as management targets.
Moved together

"Improving Performance Through Revenue and Profit Growth" moved the same way as this thread, in the same document, in 2 of its 4 moves.

2222★1234
  1. ★This thread
  2. 1Improving Performance Through Revenue and Profit Growth2×
  3. 2Recovery in demand related to electronic components and generic pharmaceuticals2×
  4. 3Decline in cash and cash equivalents and cash outflows from operating activities2×
  5. 4Increase in Total Assets, Liabilities and Net Assets2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Tohoku Chemical's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.